Subsequent analyses in PD-L1-expressing melanoma, breast- and lung cancer cell lines confirmed CMTM6 to be an important regulator of PD-L1, providing further evidence on how CRISPR library screens can facilitate the uncovering of immune escape mechanisms. Here, CD274 is linked to melanoma.